Spero Therapeutics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Spero Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-12-31 was $1.00K, a 99.57% decline year-over-year.
- Spero Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Spero Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $231.00K, a 16.61% decline year-over-year.
- Spero Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-03-31 was $188.00K, a 102.15% increase year-over-year.
- Spero Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $420.00K, a 71.03% decline from fiscal 2021.
- Spero Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $1.45M, a 33.76% decline from fiscal 2020.
- Spero Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $2.19M, a 330.91% increase from fiscal 2019.
- Spero Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2019 was $508.00K, a 51.64% increase from fiscal 2018.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $420.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | $651.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $231.00K 10-Q · filed 2023-08-10 | $1.48M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $188.00K 10-Q · filed 2023-05-11 | $1.52M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $232.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.45M 10-K · filed 2023-03-30 |
| 2021-09-30 | $826.00K 10-Q · filed 2022-11-14 | $2.38M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $277.00K 10-Q · filed 2022-08-10 | $1.75M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $93.00K 10-Q · filed 2022-05-16 | $1.74M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $2.19M 10-K · filed 2022-03-31 |
| 2020-09-30 | $201.00K 10-Q · filed 2021-11-10 | $1.11M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $269.00K 10-Q · filed 2021-08-05 | $957.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $539.00K 10-Q · filed 2021-05-06 | $988.00K derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $508.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $51.00K 10-Q · filed 2020-11-05 | $548.00K derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $300.00K 10-Q · filed 2020-08-06 | $643.00K derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $59.00K 10-Q · filed 2020-05-08 | $394.00K derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $335.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | $146.00K 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $51.00K 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |